Global Companion Diagnostic Development Services Supply, Demand and Key Producers, 2026-2032
The global Companion Diagnostic Development Services market size is expected to reach $ 3769 million by 2032, rising at a market growth of 10.9% CAGR during the forecast period (2026-2032).
Companion diagnostic development services comprise integrated technical, clinical, quality, and regulatory activities provided to pharmaceutical, biotechnology, and diagnostic companies to co-develop an in vitro diagnostic or imaging tool that is essential for the safe and effective use of a corresponding therapy. The service scope covers biomarker strategy, assay selection, reagent and algorithm development, analytical validation, clinical performance studies, clinical trial sample testing, quality-system documentation, global regulatory submissions, technology transfer, commercial deployment, and post-approval change management. Major platforms include next-generation sequencing, PCR and digital PCR, immunohistochemistry and in situ hybridization, flow cytometry, immunoassays, and digital pathology. Programs are generally advanced in parallel with therapeutic development and require coordinated decisions on clinical protocols, specimen strategy, cutoffs, intended use, and regional regulatory pathways. This study focuses on contracted development and validation services supplied to external clients by third-party laboratories, contract research organizations, and diagnostic technology companies, with an estimated blended gross margin of approximately 50%.
This report is a detailed and comprehensive analysis of the world market for Companion Diagnostic Development Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Companion Diagnostic Development Services that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Companion Diagnostic Development Services market
2. What is the demand of the global Companion Diagnostic Development Services market?
3. What is the year over year growth of the global Companion Diagnostic Development Services market?
4. What is the total value of the global Companion Diagnostic Development Services market?
5. Who are the Major Players in the global Companion Diagnostic Development Services market?
6. What are the growth factors driving the market demand?
Companion diagnostic development services comprise integrated technical, clinical, quality, and regulatory activities provided to pharmaceutical, biotechnology, and diagnostic companies to co-develop an in vitro diagnostic or imaging tool that is essential for the safe and effective use of a corresponding therapy. The service scope covers biomarker strategy, assay selection, reagent and algorithm development, analytical validation, clinical performance studies, clinical trial sample testing, quality-system documentation, global regulatory submissions, technology transfer, commercial deployment, and post-approval change management. Major platforms include next-generation sequencing, PCR and digital PCR, immunohistochemistry and in situ hybridization, flow cytometry, immunoassays, and digital pathology. Programs are generally advanced in parallel with therapeutic development and require coordinated decisions on clinical protocols, specimen strategy, cutoffs, intended use, and regional regulatory pathways. This study focuses on contracted development and validation services supplied to external clients by third-party laboratories, contract research organizations, and diagnostic technology companies, with an estimated blended gross margin of approximately 50%.
Market Trends
Companion diagnostic programs are shifting from single-marker, single-region projects toward multiplex, platform-based, and globally coordinated development. Drug sponsors increasingly engage diagnostic partners during program planning and early clinical development to reduce the risk of late assay replacement, repeat validation, or additional bridging studies. Comprehensive genomic profiling, liquid biopsy, digital pathology, and AI-enabled quantitative scoring are expanding the range of actionable biomarkers, while competition is moving beyond individual assay capabilities toward cross-platform integration, quality systems, global laboratory harmonization, and commercial deployment.Drivers
Expansion of precision therapeutics, antibody-drug conjugates, immunotherapies, and rare-disease treatments is making patient selection, response prediction, and safety stratification integral to clinical development. Regulatory expectations for coordinated drug and diagnostic development, together with sponsor demand for faster enrollment, shorter timelines, and lower late-stage submission risk, are increasing the use of specialized external partners.Restraints
Growth is constrained by limited access to high-quality clinical specimens, low biomarker prevalence, cross-border sample restrictions, and the cost of platform changes. Because diagnostic timelines must remain synchronized with the therapeutic program, changes in indication, protocol, specimen type, or cutoff can trigger additional validation, bridging, and submission work, increasing cost and delivery uncertainty.Opportunities
New demand is emerging in autoimmune, neurodegenerative, infectious, and cell and gene therapy programs beyond oncology. Local laboratory networks for multiregional trials, distributed kit deployment, single-site regulatory pathways followed by broader geographic expansion, and panel-based diagnostics that can add therapeutic claims over time all provide attractive program-extension opportunities.Challenges
Long-term risks include uncertain clinical utility of novel biomarkers, loss of diagnostic investment when a therapeutic program is discontinued, inconsistent regional requirements, and commercial testing volumes below development expectations. Digital and algorithmic diagnostics must additionally address training-data representativeness, algorithm locking, software change control, laboratory information system integration, and reproducibility across sites.Value Chain Analysis
Upstream value is supplied by antibodies, primers and probes, sequencing reagents, reference materials, biospecimens, instrument platforms, and bioinformatics tools. Midstream providers combine biomarker science, assay development, clinical laboratory operations, biostatistics, quality management, and regulatory strategy into an evidence package suitable for review. Downstream customers are primarily pharmaceutical and biotechnology companies, with diagnostic companies, central laboratories, and regional laboratory networks supporting commercial deployment. Profitability is strongest where providers control proprietary platforms, sample access, regulatory expertise, and global networks, while routine testing and stand-alone method transfer generally carry weaker pricing power.Segment Insights
End-to-end co-development typically carries the highest contract value and customer retention because responsibility continues from biomarker confirmation through approval and commercialization. By platform, next-generation sequencing remains a major growth area for multigene and tumor-agnostic programs, immunohistochemistry retains strong demand in antibody-drug conjugates and protein-expression biomarkers, and digital pathology adds value by improving scoring consistency and enabling continuous-variable cutoff development.Downstream Market Opportunities
Large pharmaceutical companies generally favor partners with global quality systems and commercialization capabilities, while emerging biotechnology companies place greater emphasis on early strategy, flexible development, and capital efficiency. Diagnostic companies and contract research organizations outsource to fill gaps in specialized platforms, clinical specimens, regulatory expertise, or regional laboratory coverage, whereas academic institutions mainly contribute to early biomarker translation and technical validation.Regional Insights
North America maintains the largest demand base because of its concentration of innovative drug pipelines, established diagnostic companies, and comparatively mature coordinated review mechanisms. Europe has strong molecular and pathology capabilities, although IVDR clinical-evidence requirements and coordination among notified bodies and medicines authorities increase program complexity. Asia-Pacific is expanding rapidly as precision-therapy development, regional trials, and local registration activity grow in China, Japan, and South Korea, creating opportunities in local sample testing and cross-border technology transfer.Competitive Landscape Analysis
The market includes three principal competitor groups. Global central laboratories and CROs provide integrated development through multiregional trial operations; major diagnostic platform companies use installed instruments, standardized reagents, and regulatory experience to support distributed commercialization; and specialist biomarker laboratories and digital pathology companies differentiate through particular technologies, specimen types, or algorithm development. Sustainable advantage depends on controlling scientific feasibility, timelines, quality systems, regulatory interaction, and post-approval deployment rather than test throughput alone.Report Scope
This report studies the global Companion Diagnostic Development Services demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Companion Diagnostic Development Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Companion Diagnostic Development Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Companion Diagnostic Development Services total market, 2021-2032, (USD Million)
- Global Companion Diagnostic Development Services total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Companion Diagnostic Development Services total market, key domestic companies, and share, (USD Million)
- Global Companion Diagnostic Development Services revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Companion Diagnostic Development Services total market by Type, CAGR, 2021-2032, (USD Million)
- Global Companion Diagnostic Development Services total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Companion Diagnostic Development Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Companion Diagnostic Development Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Companion Diagnostic Development Services Market, Segmentation by Type:
- Next-Generation Sequencing
- PCR and Digital PCR
- Immunohistochemistry and ISH
- Flow Cytometry
- Immunoassays
- Others
Global Companion Diagnostic Development Services Market, Segmentation by Development Stage:
- Discovery and Preclinical
- Early Clinical Development
- Pivotal Clinical Development
- Regulatory Submission
- Commercial Launch
- Post-Approval Lifecycle
Global Companion Diagnostic Development Services Market, Segmentation by Application:
- Pharmaceutical Companies
- Biotechnology Companies
- IVD and Diagnostic Companies
- Academic and Research Institutions
- Others
Companies Profiled:
- Labcorp
- IQVIA Laboratories
- NeoGenomics
- Almac Diagnostic Services
- Precision for Medicine
- Cerba Research
- Eurofins Clinical Diagnostics
- Medpace
- CellCarta
- Foundation Medicine
- Guardant Health
- PathAI
- Geneseeq
- Sysmex Inostics
- Thermo Fisher Scientific
- Agilent Technologies
- Leica Biosystems
- Roche Diagnostics
Key Questions Answered
1. How big is the global Companion Diagnostic Development Services market?2. What is the demand of the global Companion Diagnostic Development Services market?
3. What is the year over year growth of the global Companion Diagnostic Development Services market?
4. What is the total value of the global Companion Diagnostic Development Services market?
5. Who are the Major Players in the global Companion Diagnostic Development Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Companion Diagnostic Development Services Introduction
1.2 World Companion Diagnostic Development Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Companion Diagnostic Development Services Total Market by Region (by Headquarter Location)
1.3.1 World Companion Diagnostic Development Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.3 China Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.4 Europe Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.5 Japan Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.6 South Korea Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.8 India Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Companion Diagnostic Development Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Companion Diagnostic Development Services Consumption Value (2021-2032)
2.2 World Companion Diagnostic Development Services Consumption Value by Region
2.2.1 World Companion Diagnostic Development Services Consumption Value by Region (2021-2026)
2.2.2 World Companion Diagnostic Development Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Companion Diagnostic Development Services Consumption Value (2021-2032)
2.4 China Companion Diagnostic Development Services Consumption Value (2021-2032)
2.5 Europe Companion Diagnostic Development Services Consumption Value (2021-2032)
2.6 Japan Companion Diagnostic Development Services Consumption Value (2021-2032)
2.7 South Korea Companion Diagnostic Development Services Consumption Value (2021-2032)
2.8 ASEAN Companion Diagnostic Development Services Consumption Value (2021-2032)
2.9 India Companion Diagnostic Development Services Consumption Value (2021-2032)
3 WORLD COMPANION DIAGNOSTIC DEVELOPMENT SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Companion Diagnostic Development Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Companion Diagnostic Development Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Companion Diagnostic Development Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Companion Diagnostic Development Services in 2025
3.3 Companion Diagnostic Development Services Company Evaluation Quadrant
3.4 Companion Diagnostic Development Services Market: Overall Company Footprint Analysis
3.4.1 Companion Diagnostic Development Services Market: Region Footprint
3.4.2 Companion Diagnostic Development Services Market: Company Product Type Footprint
3.4.3 Companion Diagnostic Development Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Companion Diagnostic Development Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Companion Diagnostic Development Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Companion Diagnostic Development Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Companion Diagnostic Development Services Consumption Value Comparison
4.2.1 United States VS China: Companion Diagnostic Development Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Companion Diagnostic Development Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Companion Diagnostic Development Services Companies and Market Share, 2021-2026
4.3.1 United States Based Companion Diagnostic Development Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Companion Diagnostic Development Services Revenue, (2021-2026)
4.4 China Based Companies Companion Diagnostic Development Services Revenue and Market Share, 2021-2026
4.4.1 China Based Companion Diagnostic Development Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Companion Diagnostic Development Services Revenue, (2021-2026)
4.5 Rest of World Based Companion Diagnostic Development Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Companion Diagnostic Development Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Companion Diagnostic Development Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Next-Generation Sequencing
5.2.2 PCR and Digital PCR
5.2.3 Immunohistochemistry and ISH
5.2.4 Flow Cytometry
5.2.5 Immunoassays
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Companion Diagnostic Development Services Market Size by Type (2021-2026)
5.3.2 World Companion Diagnostic Development Services Market Size by Type (2027-2032)
5.3.3 World Companion Diagnostic Development Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World Companion Diagnostic Development Services Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Discovery and Preclinical
6.2.2 Early Clinical Development
6.2.3 Pivotal Clinical Development
6.2.4 Regulatory Submission
6.2.5 Commercial Launch
6.2.6 Post-Approval Lifecycle
6.3 Market Segment by Development Stage
6.3.1 World Companion Diagnostic Development Services Market Size by Development Stage (2021-2026)
6.3.2 World Companion Diagnostic Development Services Market Size by Development Stage (2027-2032)
6.3.3 World Companion Diagnostic Development Services Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Companion Diagnostic Development Services Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Pharmaceutical Companies
7.2.2 Biotechnology Companies
7.2.3 IVD and Diagnostic Companies
7.2.4 Academic and Research Institutions
7.2.5 Others
7.3 Market Segment by Application
7.3.1 World Companion Diagnostic Development Services Market Size by Application (2021-2026)
7.3.2 World Companion Diagnostic Development Services Market Size by Application (2027-2032)
7.3.3 World Companion Diagnostic Development Services Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Labcorp
8.1.1 Labcorp Details
8.1.2 Labcorp Major Business
8.1.3 Labcorp Companion Diagnostic Development Services Product and Services
8.1.4 Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Labcorp Recent Developments/Updates
8.1.6 Labcorp Competitive Strengths & Weaknesses
8.2 IQVIA Laboratories
8.2.1 IQVIA Laboratories Details
8.2.2 IQVIA Laboratories Major Business
8.2.3 IQVIA Laboratories Companion Diagnostic Development Services Product and Services
8.2.4 IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 IQVIA Laboratories Recent Developments/Updates
8.2.6 IQVIA Laboratories Competitive Strengths & Weaknesses
8.3 NeoGenomics
8.3.1 NeoGenomics Details
8.3.2 NeoGenomics Major Business
8.3.3 NeoGenomics Companion Diagnostic Development Services Product and Services
8.3.4 NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 NeoGenomics Recent Developments/Updates
8.3.6 NeoGenomics Competitive Strengths & Weaknesses
8.4 Almac Diagnostic Services
8.4.1 Almac Diagnostic Services Details
8.4.2 Almac Diagnostic Services Major Business
8.4.3 Almac Diagnostic Services Companion Diagnostic Development Services Product and Services
8.4.4 Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Almac Diagnostic Services Recent Developments/Updates
8.4.6 Almac Diagnostic Services Competitive Strengths & Weaknesses
8.5 Precision for Medicine
8.5.1 Precision for Medicine Details
8.5.2 Precision for Medicine Major Business
8.5.3 Precision for Medicine Companion Diagnostic Development Services Product and Services
8.5.4 Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Precision for Medicine Recent Developments/Updates
8.5.6 Precision for Medicine Competitive Strengths & Weaknesses
8.6 Cerba Research
8.6.1 Cerba Research Details
8.6.2 Cerba Research Major Business
8.6.3 Cerba Research Companion Diagnostic Development Services Product and Services
8.6.4 Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Cerba Research Recent Developments/Updates
8.6.6 Cerba Research Competitive Strengths & Weaknesses
8.7 Eurofins Clinical Diagnostics
8.7.1 Eurofins Clinical Diagnostics Details
8.7.2 Eurofins Clinical Diagnostics Major Business
8.7.3 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Services
8.7.4 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Eurofins Clinical Diagnostics Recent Developments/Updates
8.7.6 Eurofins Clinical Diagnostics Competitive Strengths & Weaknesses
8.8 Medpace
8.8.1 Medpace Details
8.8.2 Medpace Major Business
8.8.3 Medpace Companion Diagnostic Development Services Product and Services
8.8.4 Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Medpace Recent Developments/Updates
8.8.6 Medpace Competitive Strengths & Weaknesses
8.9 CellCarta
8.9.1 CellCarta Details
8.9.2 CellCarta Major Business
8.9.3 CellCarta Companion Diagnostic Development Services Product and Services
8.9.4 CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 CellCarta Recent Developments/Updates
8.9.6 CellCarta Competitive Strengths & Weaknesses
8.10 Foundation Medicine
8.10.1 Foundation Medicine Details
8.10.2 Foundation Medicine Major Business
8.10.3 Foundation Medicine Companion Diagnostic Development Services Product and Services
8.10.4 Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Foundation Medicine Recent Developments/Updates
8.10.6 Foundation Medicine Competitive Strengths & Weaknesses
8.11 Guardant Health
8.11.1 Guardant Health Details
8.11.2 Guardant Health Major Business
8.11.3 Guardant Health Companion Diagnostic Development Services Product and Services
8.11.4 Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Guardant Health Recent Developments/Updates
8.11.6 Guardant Health Competitive Strengths & Weaknesses
8.12 PathAI
8.12.1 PathAI Details
8.12.2 PathAI Major Business
8.12.3 PathAI Companion Diagnostic Development Services Product and Services
8.12.4 PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 PathAI Recent Developments/Updates
8.12.6 PathAI Competitive Strengths & Weaknesses
8.13 Geneseeq
8.13.1 Geneseeq Details
8.13.2 Geneseeq Major Business
8.13.3 Geneseeq Companion Diagnostic Development Services Product and Services
8.13.4 Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Geneseeq Recent Developments/Updates
8.13.6 Geneseeq Competitive Strengths & Weaknesses
8.14 Sysmex Inostics
8.14.1 Sysmex Inostics Details
8.14.2 Sysmex Inostics Major Business
8.14.3 Sysmex Inostics Companion Diagnostic Development Services Product and Services
8.14.4 Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Sysmex Inostics Recent Developments/Updates
8.14.6 Sysmex Inostics Competitive Strengths & Weaknesses
8.15 Thermo Fisher Scientific
8.15.1 Thermo Fisher Scientific Details
8.15.2 Thermo Fisher Scientific Major Business
8.15.3 Thermo Fisher Scientific Companion Diagnostic Development Services Product and Services
8.15.4 Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Thermo Fisher Scientific Recent Developments/Updates
8.15.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
8.16 Agilent Technologies
8.16.1 Agilent Technologies Details
8.16.2 Agilent Technologies Major Business
8.16.3 Agilent Technologies Companion Diagnostic Development Services Product and Services
8.16.4 Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Agilent Technologies Recent Developments/Updates
8.16.6 Agilent Technologies Competitive Strengths & Weaknesses
8.17 Leica Biosystems
8.17.1 Leica Biosystems Details
8.17.2 Leica Biosystems Major Business
8.17.3 Leica Biosystems Companion Diagnostic Development Services Product and Services
8.17.4 Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Leica Biosystems Recent Developments/Updates
8.17.6 Leica Biosystems Competitive Strengths & Weaknesses
8.18 Roche Diagnostics
8.18.1 Roche Diagnostics Details
8.18.2 Roche Diagnostics Major Business
8.18.3 Roche Diagnostics Companion Diagnostic Development Services Product and Services
8.18.4 Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Roche Diagnostics Recent Developments/Updates
8.18.6 Roche Diagnostics Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Companion Diagnostic Development Services Industry Chain
9.2 Companion Diagnostic Development Services Upstream Analysis
9.3 Companion Diagnostic Development Services Midstream Analysis
9.4 Companion Diagnostic Development Services Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Companion Diagnostic Development Services Introduction
1.2 World Companion Diagnostic Development Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Companion Diagnostic Development Services Total Market by Region (by Headquarter Location)
1.3.1 World Companion Diagnostic Development Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.3 China Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.4 Europe Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.5 Japan Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.6 South Korea Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.3.8 India Based Company Companion Diagnostic Development Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Companion Diagnostic Development Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Companion Diagnostic Development Services Consumption Value (2021-2032)
2.2 World Companion Diagnostic Development Services Consumption Value by Region
2.2.1 World Companion Diagnostic Development Services Consumption Value by Region (2021-2026)
2.2.2 World Companion Diagnostic Development Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Companion Diagnostic Development Services Consumption Value (2021-2032)
2.4 China Companion Diagnostic Development Services Consumption Value (2021-2032)
2.5 Europe Companion Diagnostic Development Services Consumption Value (2021-2032)
2.6 Japan Companion Diagnostic Development Services Consumption Value (2021-2032)
2.7 South Korea Companion Diagnostic Development Services Consumption Value (2021-2032)
2.8 ASEAN Companion Diagnostic Development Services Consumption Value (2021-2032)
2.9 India Companion Diagnostic Development Services Consumption Value (2021-2032)
3 WORLD COMPANION DIAGNOSTIC DEVELOPMENT SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Companion Diagnostic Development Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Companion Diagnostic Development Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Companion Diagnostic Development Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Companion Diagnostic Development Services in 2025
3.3 Companion Diagnostic Development Services Company Evaluation Quadrant
3.4 Companion Diagnostic Development Services Market: Overall Company Footprint Analysis
3.4.1 Companion Diagnostic Development Services Market: Region Footprint
3.4.2 Companion Diagnostic Development Services Market: Company Product Type Footprint
3.4.3 Companion Diagnostic Development Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Companion Diagnostic Development Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Companion Diagnostic Development Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Companion Diagnostic Development Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Companion Diagnostic Development Services Consumption Value Comparison
4.2.1 United States VS China: Companion Diagnostic Development Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Companion Diagnostic Development Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Companion Diagnostic Development Services Companies and Market Share, 2021-2026
4.3.1 United States Based Companion Diagnostic Development Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Companion Diagnostic Development Services Revenue, (2021-2026)
4.4 China Based Companies Companion Diagnostic Development Services Revenue and Market Share, 2021-2026
4.4.1 China Based Companion Diagnostic Development Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Companion Diagnostic Development Services Revenue, (2021-2026)
4.5 Rest of World Based Companion Diagnostic Development Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Companion Diagnostic Development Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Companion Diagnostic Development Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Next-Generation Sequencing
5.2.2 PCR and Digital PCR
5.2.3 Immunohistochemistry and ISH
5.2.4 Flow Cytometry
5.2.5 Immunoassays
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Companion Diagnostic Development Services Market Size by Type (2021-2026)
5.3.2 World Companion Diagnostic Development Services Market Size by Type (2027-2032)
5.3.3 World Companion Diagnostic Development Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World Companion Diagnostic Development Services Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Discovery and Preclinical
6.2.2 Early Clinical Development
6.2.3 Pivotal Clinical Development
6.2.4 Regulatory Submission
6.2.5 Commercial Launch
6.2.6 Post-Approval Lifecycle
6.3 Market Segment by Development Stage
6.3.1 World Companion Diagnostic Development Services Market Size by Development Stage (2021-2026)
6.3.2 World Companion Diagnostic Development Services Market Size by Development Stage (2027-2032)
6.3.3 World Companion Diagnostic Development Services Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Companion Diagnostic Development Services Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Pharmaceutical Companies
7.2.2 Biotechnology Companies
7.2.3 IVD and Diagnostic Companies
7.2.4 Academic and Research Institutions
7.2.5 Others
7.3 Market Segment by Application
7.3.1 World Companion Diagnostic Development Services Market Size by Application (2021-2026)
7.3.2 World Companion Diagnostic Development Services Market Size by Application (2027-2032)
7.3.3 World Companion Diagnostic Development Services Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Labcorp
8.1.1 Labcorp Details
8.1.2 Labcorp Major Business
8.1.3 Labcorp Companion Diagnostic Development Services Product and Services
8.1.4 Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Labcorp Recent Developments/Updates
8.1.6 Labcorp Competitive Strengths & Weaknesses
8.2 IQVIA Laboratories
8.2.1 IQVIA Laboratories Details
8.2.2 IQVIA Laboratories Major Business
8.2.3 IQVIA Laboratories Companion Diagnostic Development Services Product and Services
8.2.4 IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 IQVIA Laboratories Recent Developments/Updates
8.2.6 IQVIA Laboratories Competitive Strengths & Weaknesses
8.3 NeoGenomics
8.3.1 NeoGenomics Details
8.3.2 NeoGenomics Major Business
8.3.3 NeoGenomics Companion Diagnostic Development Services Product and Services
8.3.4 NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 NeoGenomics Recent Developments/Updates
8.3.6 NeoGenomics Competitive Strengths & Weaknesses
8.4 Almac Diagnostic Services
8.4.1 Almac Diagnostic Services Details
8.4.2 Almac Diagnostic Services Major Business
8.4.3 Almac Diagnostic Services Companion Diagnostic Development Services Product and Services
8.4.4 Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Almac Diagnostic Services Recent Developments/Updates
8.4.6 Almac Diagnostic Services Competitive Strengths & Weaknesses
8.5 Precision for Medicine
8.5.1 Precision for Medicine Details
8.5.2 Precision for Medicine Major Business
8.5.3 Precision for Medicine Companion Diagnostic Development Services Product and Services
8.5.4 Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Precision for Medicine Recent Developments/Updates
8.5.6 Precision for Medicine Competitive Strengths & Weaknesses
8.6 Cerba Research
8.6.1 Cerba Research Details
8.6.2 Cerba Research Major Business
8.6.3 Cerba Research Companion Diagnostic Development Services Product and Services
8.6.4 Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Cerba Research Recent Developments/Updates
8.6.6 Cerba Research Competitive Strengths & Weaknesses
8.7 Eurofins Clinical Diagnostics
8.7.1 Eurofins Clinical Diagnostics Details
8.7.2 Eurofins Clinical Diagnostics Major Business
8.7.3 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Services
8.7.4 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Eurofins Clinical Diagnostics Recent Developments/Updates
8.7.6 Eurofins Clinical Diagnostics Competitive Strengths & Weaknesses
8.8 Medpace
8.8.1 Medpace Details
8.8.2 Medpace Major Business
8.8.3 Medpace Companion Diagnostic Development Services Product and Services
8.8.4 Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Medpace Recent Developments/Updates
8.8.6 Medpace Competitive Strengths & Weaknesses
8.9 CellCarta
8.9.1 CellCarta Details
8.9.2 CellCarta Major Business
8.9.3 CellCarta Companion Diagnostic Development Services Product and Services
8.9.4 CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 CellCarta Recent Developments/Updates
8.9.6 CellCarta Competitive Strengths & Weaknesses
8.10 Foundation Medicine
8.10.1 Foundation Medicine Details
8.10.2 Foundation Medicine Major Business
8.10.3 Foundation Medicine Companion Diagnostic Development Services Product and Services
8.10.4 Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Foundation Medicine Recent Developments/Updates
8.10.6 Foundation Medicine Competitive Strengths & Weaknesses
8.11 Guardant Health
8.11.1 Guardant Health Details
8.11.2 Guardant Health Major Business
8.11.3 Guardant Health Companion Diagnostic Development Services Product and Services
8.11.4 Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Guardant Health Recent Developments/Updates
8.11.6 Guardant Health Competitive Strengths & Weaknesses
8.12 PathAI
8.12.1 PathAI Details
8.12.2 PathAI Major Business
8.12.3 PathAI Companion Diagnostic Development Services Product and Services
8.12.4 PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 PathAI Recent Developments/Updates
8.12.6 PathAI Competitive Strengths & Weaknesses
8.13 Geneseeq
8.13.1 Geneseeq Details
8.13.2 Geneseeq Major Business
8.13.3 Geneseeq Companion Diagnostic Development Services Product and Services
8.13.4 Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Geneseeq Recent Developments/Updates
8.13.6 Geneseeq Competitive Strengths & Weaknesses
8.14 Sysmex Inostics
8.14.1 Sysmex Inostics Details
8.14.2 Sysmex Inostics Major Business
8.14.3 Sysmex Inostics Companion Diagnostic Development Services Product and Services
8.14.4 Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Sysmex Inostics Recent Developments/Updates
8.14.6 Sysmex Inostics Competitive Strengths & Weaknesses
8.15 Thermo Fisher Scientific
8.15.1 Thermo Fisher Scientific Details
8.15.2 Thermo Fisher Scientific Major Business
8.15.3 Thermo Fisher Scientific Companion Diagnostic Development Services Product and Services
8.15.4 Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Thermo Fisher Scientific Recent Developments/Updates
8.15.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
8.16 Agilent Technologies
8.16.1 Agilent Technologies Details
8.16.2 Agilent Technologies Major Business
8.16.3 Agilent Technologies Companion Diagnostic Development Services Product and Services
8.16.4 Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Agilent Technologies Recent Developments/Updates
8.16.6 Agilent Technologies Competitive Strengths & Weaknesses
8.17 Leica Biosystems
8.17.1 Leica Biosystems Details
8.17.2 Leica Biosystems Major Business
8.17.3 Leica Biosystems Companion Diagnostic Development Services Product and Services
8.17.4 Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Leica Biosystems Recent Developments/Updates
8.17.6 Leica Biosystems Competitive Strengths & Weaknesses
8.18 Roche Diagnostics
8.18.1 Roche Diagnostics Details
8.18.2 Roche Diagnostics Major Business
8.18.3 Roche Diagnostics Companion Diagnostic Development Services Product and Services
8.18.4 Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Roche Diagnostics Recent Developments/Updates
8.18.6 Roche Diagnostics Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Companion Diagnostic Development Services Industry Chain
9.2 Companion Diagnostic Development Services Upstream Analysis
9.3 Companion Diagnostic Development Services Midstream Analysis
9.4 Companion Diagnostic Development Services Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Companion Diagnostic Development Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Companion Diagnostic Development Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Companion Diagnostic Development Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Companion Diagnostic Development Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Companion Diagnostic Development Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Companion Diagnostic Development Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Companion Diagnostic Development Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Companion Diagnostic Development Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Companion Diagnostic Development Services Players in 2025
Table 12. World Companion Diagnostic Development Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Companion Diagnostic Development Services Company Evaluation Quadrant
Table 14. Head Office of Key Companion Diagnostic Development Services Players
Table 15. Companion Diagnostic Development Services Market: Company Product Type Footprint
Table 16. Companion Diagnostic Development Services Market: Company Product Application Footprint
Table 17. Companion Diagnostic Development Services Mergers & Acquisitions Activity
Table 18. United States VS China Companion Diagnostic Development Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Companion Diagnostic Development Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Companion Diagnostic Development Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Companion Diagnostic Development Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 23. China Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Companion Diagnostic Development Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Companion Diagnostic Development Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 29. World Companion Diagnostic Development Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Companion Diagnostic Development Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Companion Diagnostic Development Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Companion Diagnostic Development Services Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Companion Diagnostic Development Services Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World Companion Diagnostic Development Services Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World Companion Diagnostic Development Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Companion Diagnostic Development Services Market Size by Application (2021-2026) & (USD Million)
Table 37. World Companion Diagnostic Development Services Market Size by Application (2027-2032) & (USD Million)
Table 38. Labcorp Basic Information, Manufacturing Base and Competitors
Table 39. Labcorp Major Business
Table 40. Labcorp Companion Diagnostic Development Services Product and Services
Table 41. Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Labcorp Recent Developments/Updates
Table 43. Labcorp Competitive Strengths & Weaknesses
Table 44. IQVIA Laboratories Basic Information, Manufacturing Base and Competitors
Table 45. IQVIA Laboratories Major Business
Table 46. IQVIA Laboratories Companion Diagnostic Development Services Product and Services
Table 47. IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. IQVIA Laboratories Recent Developments/Updates
Table 49. IQVIA Laboratories Competitive Strengths & Weaknesses
Table 50. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 51. NeoGenomics Major Business
Table 52. NeoGenomics Companion Diagnostic Development Services Product and Services
Table 53. NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. NeoGenomics Recent Developments/Updates
Table 55. NeoGenomics Competitive Strengths & Weaknesses
Table 56. Almac Diagnostic Services Basic Information, Manufacturing Base and Competitors
Table 57. Almac Diagnostic Services Major Business
Table 58. Almac Diagnostic Services Companion Diagnostic Development Services Product and Services
Table 59. Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Almac Diagnostic Services Recent Developments/Updates
Table 61. Almac Diagnostic Services Competitive Strengths & Weaknesses
Table 62. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 63. Precision for Medicine Major Business
Table 64. Precision for Medicine Companion Diagnostic Development Services Product and Services
Table 65. Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Precision for Medicine Recent Developments/Updates
Table 67. Precision for Medicine Competitive Strengths & Weaknesses
Table 68. Cerba Research Basic Information, Manufacturing Base and Competitors
Table 69. Cerba Research Major Business
Table 70. Cerba Research Companion Diagnostic Development Services Product and Services
Table 71. Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Cerba Research Recent Developments/Updates
Table 73. Cerba Research Competitive Strengths & Weaknesses
Table 74. Eurofins Clinical Diagnostics Basic Information, Manufacturing Base and Competitors
Table 75. Eurofins Clinical Diagnostics Major Business
Table 76. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Services
Table 77. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Eurofins Clinical Diagnostics Recent Developments/Updates
Table 79. Eurofins Clinical Diagnostics Competitive Strengths & Weaknesses
Table 80. Medpace Basic Information, Manufacturing Base and Competitors
Table 81. Medpace Major Business
Table 82. Medpace Companion Diagnostic Development Services Product and Services
Table 83. Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Medpace Recent Developments/Updates
Table 85. Medpace Competitive Strengths & Weaknesses
Table 86. CellCarta Basic Information, Manufacturing Base and Competitors
Table 87. CellCarta Major Business
Table 88. CellCarta Companion Diagnostic Development Services Product and Services
Table 89. CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. CellCarta Recent Developments/Updates
Table 91. CellCarta Competitive Strengths & Weaknesses
Table 92. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 93. Foundation Medicine Major Business
Table 94. Foundation Medicine Companion Diagnostic Development Services Product and Services
Table 95. Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Foundation Medicine Recent Developments/Updates
Table 97. Foundation Medicine Competitive Strengths & Weaknesses
Table 98. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 99. Guardant Health Major Business
Table 100. Guardant Health Companion Diagnostic Development Services Product and Services
Table 101. Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Guardant Health Recent Developments/Updates
Table 103. Guardant Health Competitive Strengths & Weaknesses
Table 104. PathAI Basic Information, Manufacturing Base and Competitors
Table 105. PathAI Major Business
Table 106. PathAI Companion Diagnostic Development Services Product and Services
Table 107. PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. PathAI Recent Developments/Updates
Table 109. PathAI Competitive Strengths & Weaknesses
Table 110. Geneseeq Basic Information, Manufacturing Base and Competitors
Table 111. Geneseeq Major Business
Table 112. Geneseeq Companion Diagnostic Development Services Product and Services
Table 113. Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Geneseeq Recent Developments/Updates
Table 115. Geneseeq Competitive Strengths & Weaknesses
Table 116. Sysmex Inostics Basic Information, Manufacturing Base and Competitors
Table 117. Sysmex Inostics Major Business
Table 118. Sysmex Inostics Companion Diagnostic Development Services Product and Services
Table 119. Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Sysmex Inostics Recent Developments/Updates
Table 121. Sysmex Inostics Competitive Strengths & Weaknesses
Table 122. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 123. Thermo Fisher Scientific Major Business
Table 124. Thermo Fisher Scientific Companion Diagnostic Development Services Product and Services
Table 125. Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Thermo Fisher Scientific Recent Developments/Updates
Table 127. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 128. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 129. Agilent Technologies Major Business
Table 130. Agilent Technologies Companion Diagnostic Development Services Product and Services
Table 131. Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Agilent Technologies Recent Developments/Updates
Table 133. Agilent Technologies Competitive Strengths & Weaknesses
Table 134. Leica Biosystems Basic Information, Manufacturing Base and Competitors
Table 135. Leica Biosystems Major Business
Table 136. Leica Biosystems Companion Diagnostic Development Services Product and Services
Table 137. Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Leica Biosystems Recent Developments/Updates
Table 139. Leica Biosystems Competitive Strengths & Weaknesses
Table 140. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 141. Roche Diagnostics Major Business
Table 142. Roche Diagnostics Companion Diagnostic Development Services Product and Services
Table 143. Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Roche Diagnostics Recent Developments/Updates
Table 145. Roche Diagnostics Competitive Strengths & Weaknesses
Table 146. Global Key Players of Companion Diagnostic Development Services Upstream (Raw Materials)
Table 147. Global Companion Diagnostic Development Services Typical Customers
Table 1. World Companion Diagnostic Development Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Companion Diagnostic Development Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Companion Diagnostic Development Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Companion Diagnostic Development Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Companion Diagnostic Development Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Companion Diagnostic Development Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Companion Diagnostic Development Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Companion Diagnostic Development Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Companion Diagnostic Development Services Players in 2025
Table 12. World Companion Diagnostic Development Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Companion Diagnostic Development Services Company Evaluation Quadrant
Table 14. Head Office of Key Companion Diagnostic Development Services Players
Table 15. Companion Diagnostic Development Services Market: Company Product Type Footprint
Table 16. Companion Diagnostic Development Services Market: Company Product Application Footprint
Table 17. Companion Diagnostic Development Services Mergers & Acquisitions Activity
Table 18. United States VS China Companion Diagnostic Development Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Companion Diagnostic Development Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Companion Diagnostic Development Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Companion Diagnostic Development Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 23. China Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Companion Diagnostic Development Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Companion Diagnostic Development Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Companion Diagnostic Development Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Companion Diagnostic Development Services Revenue Market Share (2021-2026)
Table 29. World Companion Diagnostic Development Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Companion Diagnostic Development Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Companion Diagnostic Development Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Companion Diagnostic Development Services Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Companion Diagnostic Development Services Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World Companion Diagnostic Development Services Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World Companion Diagnostic Development Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Companion Diagnostic Development Services Market Size by Application (2021-2026) & (USD Million)
Table 37. World Companion Diagnostic Development Services Market Size by Application (2027-2032) & (USD Million)
Table 38. Labcorp Basic Information, Manufacturing Base and Competitors
Table 39. Labcorp Major Business
Table 40. Labcorp Companion Diagnostic Development Services Product and Services
Table 41. Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Labcorp Recent Developments/Updates
Table 43. Labcorp Competitive Strengths & Weaknesses
Table 44. IQVIA Laboratories Basic Information, Manufacturing Base and Competitors
Table 45. IQVIA Laboratories Major Business
Table 46. IQVIA Laboratories Companion Diagnostic Development Services Product and Services
Table 47. IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. IQVIA Laboratories Recent Developments/Updates
Table 49. IQVIA Laboratories Competitive Strengths & Weaknesses
Table 50. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 51. NeoGenomics Major Business
Table 52. NeoGenomics Companion Diagnostic Development Services Product and Services
Table 53. NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. NeoGenomics Recent Developments/Updates
Table 55. NeoGenomics Competitive Strengths & Weaknesses
Table 56. Almac Diagnostic Services Basic Information, Manufacturing Base and Competitors
Table 57. Almac Diagnostic Services Major Business
Table 58. Almac Diagnostic Services Companion Diagnostic Development Services Product and Services
Table 59. Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Almac Diagnostic Services Recent Developments/Updates
Table 61. Almac Diagnostic Services Competitive Strengths & Weaknesses
Table 62. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 63. Precision for Medicine Major Business
Table 64. Precision for Medicine Companion Diagnostic Development Services Product and Services
Table 65. Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Precision for Medicine Recent Developments/Updates
Table 67. Precision for Medicine Competitive Strengths & Weaknesses
Table 68. Cerba Research Basic Information, Manufacturing Base and Competitors
Table 69. Cerba Research Major Business
Table 70. Cerba Research Companion Diagnostic Development Services Product and Services
Table 71. Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Cerba Research Recent Developments/Updates
Table 73. Cerba Research Competitive Strengths & Weaknesses
Table 74. Eurofins Clinical Diagnostics Basic Information, Manufacturing Base and Competitors
Table 75. Eurofins Clinical Diagnostics Major Business
Table 76. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Services
Table 77. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Eurofins Clinical Diagnostics Recent Developments/Updates
Table 79. Eurofins Clinical Diagnostics Competitive Strengths & Weaknesses
Table 80. Medpace Basic Information, Manufacturing Base and Competitors
Table 81. Medpace Major Business
Table 82. Medpace Companion Diagnostic Development Services Product and Services
Table 83. Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Medpace Recent Developments/Updates
Table 85. Medpace Competitive Strengths & Weaknesses
Table 86. CellCarta Basic Information, Manufacturing Base and Competitors
Table 87. CellCarta Major Business
Table 88. CellCarta Companion Diagnostic Development Services Product and Services
Table 89. CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. CellCarta Recent Developments/Updates
Table 91. CellCarta Competitive Strengths & Weaknesses
Table 92. Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table 93. Foundation Medicine Major Business
Table 94. Foundation Medicine Companion Diagnostic Development Services Product and Services
Table 95. Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Foundation Medicine Recent Developments/Updates
Table 97. Foundation Medicine Competitive Strengths & Weaknesses
Table 98. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 99. Guardant Health Major Business
Table 100. Guardant Health Companion Diagnostic Development Services Product and Services
Table 101. Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Guardant Health Recent Developments/Updates
Table 103. Guardant Health Competitive Strengths & Weaknesses
Table 104. PathAI Basic Information, Manufacturing Base and Competitors
Table 105. PathAI Major Business
Table 106. PathAI Companion Diagnostic Development Services Product and Services
Table 107. PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. PathAI Recent Developments/Updates
Table 109. PathAI Competitive Strengths & Weaknesses
Table 110. Geneseeq Basic Information, Manufacturing Base and Competitors
Table 111. Geneseeq Major Business
Table 112. Geneseeq Companion Diagnostic Development Services Product and Services
Table 113. Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Geneseeq Recent Developments/Updates
Table 115. Geneseeq Competitive Strengths & Weaknesses
Table 116. Sysmex Inostics Basic Information, Manufacturing Base and Competitors
Table 117. Sysmex Inostics Major Business
Table 118. Sysmex Inostics Companion Diagnostic Development Services Product and Services
Table 119. Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Sysmex Inostics Recent Developments/Updates
Table 121. Sysmex Inostics Competitive Strengths & Weaknesses
Table 122. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 123. Thermo Fisher Scientific Major Business
Table 124. Thermo Fisher Scientific Companion Diagnostic Development Services Product and Services
Table 125. Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Thermo Fisher Scientific Recent Developments/Updates
Table 127. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 128. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 129. Agilent Technologies Major Business
Table 130. Agilent Technologies Companion Diagnostic Development Services Product and Services
Table 131. Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Agilent Technologies Recent Developments/Updates
Table 133. Agilent Technologies Competitive Strengths & Weaknesses
Table 134. Leica Biosystems Basic Information, Manufacturing Base and Competitors
Table 135. Leica Biosystems Major Business
Table 136. Leica Biosystems Companion Diagnostic Development Services Product and Services
Table 137. Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Leica Biosystems Recent Developments/Updates
Table 139. Leica Biosystems Competitive Strengths & Weaknesses
Table 140. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 141. Roche Diagnostics Major Business
Table 142. Roche Diagnostics Companion Diagnostic Development Services Product and Services
Table 143. Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Roche Diagnostics Recent Developments/Updates
Table 145. Roche Diagnostics Competitive Strengths & Weaknesses
Table 146. Global Key Players of Companion Diagnostic Development Services Upstream (Raw Materials)
Table 147. Global Companion Diagnostic Development Services Typical Customers
LIST OF FIGURES
Figure 1. Companion Diagnostic Development Services Picture
Figure 2. World Companion Diagnostic Development Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Companion Diagnostic Development Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Companion Diagnostic Development Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Companion Diagnostic Development Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 13. Companion Diagnostic Development Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Companion Diagnostic Development Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Companion Diagnostic Development Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Companion Diagnostic Development Services Markets in 2025
Figure 27. United States VS China: Companion Diagnostic Development Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Companion Diagnostic Development Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Companion Diagnostic Development Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Companion Diagnostic Development Services Market Size Market Share by Type in 2025
Figure 31. Next-Generation Sequencing
Figure 32. PCR and Digital PCR
Figure 33. Immunohistochemistry and ISH
Figure 34. Flow Cytometry
Figure 35. Immunoassays
Figure 36. Others
Figure 37. World Companion Diagnostic Development Services Market Size Market Share by Type (2021-2032)
Figure 38. World Companion Diagnostic Development Services Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 39. World Companion Diagnostic Development Services Market Size Market Share by Development Stage in 2025
Figure 40. Discovery and Preclinical
Figure 41. Early Clinical Development
Figure 42. Pivotal Clinical Development
Figure 43. Regulatory Submission
Figure 44. Commercial Launch
Figure 45. Post-Approval Lifecycle
Figure 46. World Companion Diagnostic Development Services Market Size Market Share by Development Stage (2021-2032)
Figure 47. World Companion Diagnostic Development Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Companion Diagnostic Development Services Market Size Market Share by Application in 2025
Figure 49. Pharmaceutical Companies
Figure 50. Biotechnology Companies
Figure 51. IVD and Diagnostic Companies
Figure 52. Academic and Research Institutions
Figure 53. Others
Figure 54. World Companion Diagnostic Development Services Market Size Market Share by Application (2021-2032)
Figure 55. Companion Diagnostic Development Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Companion Diagnostic Development Services Picture
Figure 2. World Companion Diagnostic Development Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Companion Diagnostic Development Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Companion Diagnostic Development Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Companion Diagnostic Development Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Companion Diagnostic Development Services Revenue (2021-2032) & (USD Million)
Figure 13. Companion Diagnostic Development Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Companion Diagnostic Development Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Companion Diagnostic Development Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Companion Diagnostic Development Services Markets in 2025
Figure 27. United States VS China: Companion Diagnostic Development Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Companion Diagnostic Development Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Companion Diagnostic Development Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Companion Diagnostic Development Services Market Size Market Share by Type in 2025
Figure 31. Next-Generation Sequencing
Figure 32. PCR and Digital PCR
Figure 33. Immunohistochemistry and ISH
Figure 34. Flow Cytometry
Figure 35. Immunoassays
Figure 36. Others
Figure 37. World Companion Diagnostic Development Services Market Size Market Share by Type (2021-2032)
Figure 38. World Companion Diagnostic Development Services Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 39. World Companion Diagnostic Development Services Market Size Market Share by Development Stage in 2025
Figure 40. Discovery and Preclinical
Figure 41. Early Clinical Development
Figure 42. Pivotal Clinical Development
Figure 43. Regulatory Submission
Figure 44. Commercial Launch
Figure 45. Post-Approval Lifecycle
Figure 46. World Companion Diagnostic Development Services Market Size Market Share by Development Stage (2021-2032)
Figure 47. World Companion Diagnostic Development Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Companion Diagnostic Development Services Market Size Market Share by Application in 2025
Figure 49. Pharmaceutical Companies
Figure 50. Biotechnology Companies
Figure 51. IVD and Diagnostic Companies
Figure 52. Academic and Research Institutions
Figure 53. Others
Figure 54. World Companion Diagnostic Development Services Market Size Market Share by Application (2021-2032)
Figure 55. Companion Diagnostic Development Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
